Back HCV Prevention HCV Sexual Transmission IAS 2015: PrEP and the Risk of Hepatitis C Virus Infection [VIDEO]

IAS 2015: PrEP and the Risk of Hepatitis C Virus Infection [VIDEO]

alt

 Are gay and bisexual men who take Truvada for HIV pre-exposure prophylaxis (PrEP) at greater risk for sexually transmitted hepatitis C virus (HCV) infection? Experts discussed this issue and others at a media briefing on HIV and hepatitis coinfection at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention last month in Vancouver.

[HIV/hepatitis coinfection press briefing, IAS 2015, July 22, 2015]

The amount of sexually transmitted diseases other than HIV is so high in this population, explained Jürgen Rockstroh from the University of Bonn. "That risk behavior already exists with or without PrEP -- PrEP is just helping to prevent the HIV part, but it's not going to change the other part."

"Test and treat" in the hepatitis C environment could have an impact in reducing HCV transmission during acute infection when viral load is high, suggested Linda-Gail Bekker from the Desmund Tutu HIV Centre in Cape Town. But currently the only approved treatment for acute hepatitis C is pegylated interferon, which no one wants, Rockstroh noted.

"It will be very interesting to follow the epidemiology [of sexually transmitted HCV] in the next few years," concluded Tracy Swan from the Treatment Action Group.

8/12/15

Source

8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Press briefing, July 22, 2015.